PortViewPortView
HLTH logo

Tema Healthcare AI (HLTH) ETF Holdings & Analysis

ETFOther

$29.89+3.43%
1-year price historyRange $25.18 – $30.57
52-week range$29.89
$24.88$31.71

Track HLTH in your portfolio for free · Portfolio tracker

What HLTH does

Tema Healthcare AI ETF is an actively managed exchange-traded fund that focuses on the intersection of artificial intelligence and healthcare. It targets global life science, tech, and medical companies driving AI-integrated drug discovery, robotic surgery, and healthcare operational efficiencies.

Fund profile

Category
Other
AUM
$1.20M
Holdings
10
52-week high
$31.71
52-week low
$24.88

Top holdings

Top 1052%
HoldingWeight
10X GENOMICS INC7.06%
TWIST BIOSCIENCE CORP5.73%
NATERA INC5.49%
INTUITIVE SURGICAL INC5.38%
ILLUMINA INC5.15%
REVOLUTION MEDICINES INC4.71%
COGENT BIOSCIENCES INC4.69%
CYTOKINETICS INC4.67%
GUARDANT HEALTH INC4.57%
THERMO FISHER SCIENTIFIC INC4.53%

Geographic allocation

United States98.82%
Hong Kong0.82%
Other0.35%

PortView Portfolio Insights

PortView analyzes how HLTH fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze HLTH in PortView →

Related securities

Related stocks

Frequently asked questions

What does HLTH track?
HLTH is the Tema Healthcare AI ETF, a Other ETF.
What is the expense ratio of HLTH?
Expense ratio data for HLTH is shown on the page when available from our data provider.
What are the largest holdings in HLTH?
Top holdings include TXG, TWST, NTRA, ISRG, ILMN.
How can PortView analyze HLTH overlap with other ETFs?
PortView computes the holdings overlap between HLTH and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.